| Characteristics | |
| Median age (range), years | 26 (2–58) | Male sex, n (%) | 231 (58.6%) | Diagnosis | | AML, n (%) | 160 (40.6%) | ALL, n (%) | 133 (33.8%) | CML, n (%) | 22 (5.6%) | MDS, n (%) | 41 (10.4%) | Others, n (%) | 38 (9.6%) | Disease status, SR (%) | 301 (76.4%) | Conditioning regimen | | MA, n (%) | 394 (100%) | Number of HLA-A, B, DR mismatched, n (%) | | 0 | 3 (0.8%) | 1 | 22 (5.6%) | 2 | 87 (22.1%) | 3 | 282 (71.6%) | Donor-recipient sex match, n (%) | | Male-male | 149 (37.8%) | Male-female | 102 (25.9%) | Female-male | 84 (21.3%) | Female-female | 59 (15%) | Donor-recipient relationship, n (%) | | Father-child | 150 (38.1%) | Mother-child | 57 (14.5%) | Sibling-sibling | 117 (29.%) | Child-parent | 58 (14.7%) | Others | 12 (3.0%) | ABO matched, n (%) | | Matched | 224 (56.9%) | Major mismatched | 74 (18.8%) | Minor mismatched | 22 (5.6%) | Bidirect mismatched | 74 (18.8%) | Cell compositions in allografts, median (range) | | Infused nuclear cells, 108/kg | 8.23 (1.78–23.69) | Infused CD34+ cells, 106/kg | 2.61 (0.39–16.82) | Infused lymphocytes, 108/kg | 2.93 (0.16–9.49) | Infused CD3+ cells, 108/kg | 2.0 (0.1–5.93) | Infused CD4+ cells, 108/kg | 1.1 (0.15–3.94) | Infused CD8+ cells, 108/kg | 0.69 (0.05–2.47) | Infused CD14+ cells, 108/kg | 1.48 (0.19–6.13) | aGVHD | | Grade 0-I aGVHD | 259 (65.7%) | Grade II–IV aGVHD | 135 (34.3%) | cGVHD | | No cGVHD | 266 (67.5%) | cGVHD | 128 (32.5%) |
|
|